News about Global Pharma

B. Braun Medical Receives FDA Approval for Piperacillin, Tazobactam in DUPLEX Drug Delivery System

Piperacillin and Tazobactam in the DUPLEX Drug Delivery System is a ready-to-activate, two-compartment container that keeps pre-measured medication and diluent separate until the provider is ready to administer at the bedside by simply folding, squeezing, and shaking to reconstitute.

Global Pharma | 10/04/2025 | By Abha |  736

EssilorLuxottica Announces US Launch of Nuance Audio Glasses

Paving the way for a disruptive new category in the med-tech space, Nuance Audio Glasses are FDA-registered over-the-counter (OTC) hearing aids, allowing consumers to address their hearing needs without requiring a prescription or an audiologist visit. A

Global Pharma | 09/04/2025 | By Manvi |  861

ZIM Labs and Globalpharma Collaborate to Commercialise Oral Thin Film Products in GCC Region

ZIM Laboratories has partnered with UAE-based Globalpharma to license its proprietary Oral Thin Film technology and supply products for regional commercialisation, expanding its footprint in the Middle Eastern pharmaceutical market.

Global Pharma | 09/04/2025 | By Manvi |  475

ZEISS Gets FDA Clearance for INTRABEAM 700

ZEISS Medical Technology is dedicated to shaping modern oncology. The company recently received 510(k) clearance from the US Food and Drug Administration (FDA) for INTRABEAM® 700 – a leading-edge platform that provides robotic-assisted precision to support intraoperative radiation therapy (IORT).

Global Pharma | 09/04/2025 | By Manvi |  254

AmacaThera, Global Pharma Giant Team Up to Create Advanced Long-Acting Biologic Using AmacaGel

Through this partnership, a single-injection, long-acting biologic will be developed using AmacaThera's advanced hydrogel delivery platform, AmacaGel™, in combination with the partner's therapeutic. <br />

Global Pharma | 09/04/2025 | By Abha |  298

Korean Ministry Grants Approval to GC Biopharma's BARYTHRAX Anthrax Vaccine

With the approval by MFDS, BARYTHRAX has become Korea's 39th novel drug.

Global Pharma | 09/04/2025 | By Abha |  322

Volta Medical Appoints Bill Hoffman as Executive Chairman of Board of Directors

Volta Medical, a health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists, announced the appointment of Bill Hoffman as Executive Chairman of its Board of Directors.

Global Pharma | 08/04/2025 | By Manvi |  303

Innocan Pharma Files Divisional Patent in China for Liposome-based CBD Technology

Innocan Pharma has filed a divisional patent application in China for its liposome-based CBD delivery technology, marking a strategic move to expand its IP footprint in Asia’s rapidly growing pharmaceutical market.

Global Pharma | 08/04/2025 | By Manvi |  274

Stramsen Biotech Secures USD 25 Million Funding Commitment from GEM Global Yield LLC SCS

Stramsen Biotech Inc., a plant-based biopharmaceutical company, has secured USD 25 million in funding from GEM Global Yield LLC SCS to support its clinical development, global expansion, and the path toward a public listing.

Global Pharma | 08/04/2025 | By Manvi |  423

Ventris Medical Receives FDA 510(k) Clearance for Backpack Biologic Scaffold in Spinal Fusion Procedures

Ventris Medical announced that the United States Food and Drug Administration has granted 510(k) clearance for Backpack® (Porous Biologic Scaffold, K250556) for use in the Intervertebral Disc Space.

Global Pharma | 08/04/2025 | By Manvi |  157